HOME >> MEDICINE >> NEWS
Rheumatoid arthritis patients caught in middle of doctors' disagreement over hand surgery

ANN ARBOR, MI More than two million Americans with rheumatoid arthritis are caught in the middle of a debate among physicians over which treatment medications or hand surgery will help their ravaged fingers and wrists most.

And a new University of Michigan Health System study finds that entrenched attitudes and lack of communication among rheumatologists and hand surgeons, and a dearth of data comparing the two strategies, are keeping the controversy going.

Only large studies evaluating the effectiveness of various hand operations, the researchers say, will quell the debate and help patients get consistent and beneficial care no matter what kind of doctor they see or where they live.

The multidisciplinary U-M research team reports its latest findings about attitudes among rheumatologists and surgeons in the current issue of the Journal of Rheumatology. They published previous attitude-related results in the Journal of Hand Surgery earlier this year, and last October they reported dramatic state-by-state variation in hand surgery rates in the journal Arthritis & Rheumatism.

"What we're finding is that rheumatoid arthritis care can vary tremendously depending on where patients live, what type of physician they're referred to, how much cross-training and interaction those physicians have with others, and what an individual doctor personally thinks of other specialties," says Amy Alderman, M.D., M.P.H., lead author of all three studies and a resident in Plastic & Reconstructive surgery at UMHS. "Since this is a debilitating, chronic condition that affects so many, it's very concerning that we don't have a consensus or communication among providers."

Alderman and her U-M colleagues -- who include a rheumatologist, a senior hand surgeon, general internists and a statistician -- surveyed nearly 1,000 doctors selected by random sampling from among the members of top rheumatology and hand surgery societies. For the October paper,
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
25-Jul-2003


Page: 1 2 3 4 5

Related medicine news :

1. Rheumatoid arthritis patients have double the risk of heart failure
2. Rheumatoid arthritis linked to excess risk of congestive heart failure
3. Rheumatoid arthritis patients at higher risk for unrecognized heart disease and cardiac sudden death
4. Rheumatoid arthritis causes increased complications and health care costs in inpatient and outpatient settings
5. ENBREL (Etanercept) Receives FDA Approval For Treatment Of Juvenile Rheumatoid Arthritis
6. Positive Results Of Pivotal Phase III Trial With ENBREL In Patients With Early, Active Rheumatoid Arthritis
7. Hopkins Researchers Develop New Therapy For Autoimmune Disorders Such As Rheumatoid Arthritis And Lupus
8. Changing Drug Delivery For Rheumatoid Arthritis Patients Increases Effectiveness, Lowers Costs
9. Immunosuppressive Treatment Is Important For Sufferers Of Rheumatoid Arthritis
10. University seeks recruits for arthritis study
11. A shallow hip socket predicts osteoarthritis of the hip

Post Your Comments:
(Date:4/1/2015)... 2015 On April 1st, 2015, Dr. Jason Helfrich, ... on Better TV to discuss the epidemic known as “Text Neck.” ... the varying angle in which it is bent forward, such as ... the cervical spine can cause poor posture often times leading to ... more people spend hours on their cell phone device emailing, keeping ...
(Date:4/1/2015)... 01, 2015 Poisonous plants (poison ivy, ... change in recent years, increasing significantly in number and ... if exposed to poison plants (according to the American ... prepare for summer adventures in nature, they should be ... reaction is greater than ever. This year, Ivarest adds ...
(Date:3/31/2015)... Creek, Michigan (PRWEB) March 31, 2015 On ... retired NFL All-Pro Lawrence Taylor to discuss the problem of ... Taylor, through his own history of drug abuse and recovery, ... process. , Nicknamed “L.T.” by his teammates on the New ... the league due to failed drug tests, yet he was ...
(Date:3/31/2015)... In conjunction with the Asbestos ... the Mesothelioma Applied Research Foundation (Meso Foundation) announced ... complement its existing work in mesothelioma research, education, ... the Meso Foundation’s mission, we want to eliminate ... to asbestos, including mesothelioma,” said the Meso Foundation’s ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Simeon Boyd, ... a nearly $4 million, five-year grant from the National ... team of physicians and scientists from more than 10 ... including Australia, Brazil, Bulgaria, Germany, Hungary, Italy and the ... the bony plates of the skull in infants. , ...
Breaking Medicine News(10 mins):Health News:Dr. Jason Helfrich, Co-Founder of 100% Chiropractic, is a Guest on Better TV to Discuss “Text Neck” 2Health News:New Ivarest Poison Ivy Itch Spray Provides All-Day Comfort 2Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Mesothelioma Research Organization Announces New Prevention Program 2Health News:Mesothelioma Research Organization Announces New Prevention Program 3Health News:International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants 2Health News:International team of researchers led by UC Davis receives $4 million NIH grant to study skull disorder in infants 3
(Date:3/31/2015)... MALVERN, Pa. , March 31, 2015  SCILEX ... commercialization of products focused on the treatment of pain, ... Tokyo Japan ), a member of ITOCHU ... one of the three leading sogo shosha (general trading ... a strategic investment in SCILEX.  ICF has worked closely ...
(Date:3/31/2015)...  SynCardia Systems, Inc. has received FDA approval to ... the effective use of its 50cc SynCardia temporary Total ... The FDA approval will allow SynCardia to launch ... patients. Patients enrolled in this study will receive the ... a donor heart transplant. (Caution-In the United States, ...
(Date:3/31/2015)... VICTORIA, BC , March 31, 2015 /CNW/ - T-Bird ... company focused on developing premium quality medical marijuana products ... the Marihuana for Medical Purposes Regulations ( Canada ... has received notice from The Corporation of the District ... rezoning approval of the Company,s premises which now allows ...
Breaking Medicine Technology:SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 2FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 3FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart 4T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 2T-Bird Pharma Inc. Announces Final Municipal Rezoning Approval 3
Cached News: